Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples